These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22318315)

  • 21. Insulin action in the double incretin receptor knockout mouse.
    Ayala JE; Bracy DP; Hansotia T; Flock G; Seino Y; Wasserman DH; Drucker DJ
    Diabetes; 2008 Feb; 57(2):288-97. PubMed ID: 17977951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice.
    Thomas A; Belaidi E; Aron-Wisnewsky J; van der Zon GC; Levy P; Clement K; Pepin JL; Godin-Ribuot D; Guigas B
    Sci Rep; 2016 Apr; 6():24618. PubMed ID: 27094951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice.
    Newberry EP; Xie Y; Kennedy SM; Luo J; Davidson NO
    Hepatology; 2006 Nov; 44(5):1191-205. PubMed ID: 17058218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
    Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
    Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance.
    Ayala JE; Bracy DP; James FD; Burmeister MA; Wasserman DH; Drucker DJ
    Endocrinology; 2010 Oct; 151(10):4678-87. PubMed ID: 20685876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance.
    Guerre-Millo M; Rouault C; Poulain P; André J; Poitout V; Peters JM; Gonzalez FJ; Fruchart JC; Reach G; Staels B
    Diabetes; 2001 Dec; 50(12):2809-14. PubMed ID: 11723064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adropin regulates hepatic glucose production via PP2A/AMPK pathway in insulin-resistant hepatocytes.
    Chen X; Chen S; Shen T; Yang W; Chen Q; Zhang P; You Y; Sun X; Xu H; Tang Y; Mi J; Yang Y; Ling W
    FASEB J; 2020 Aug; 34(8):10056-10072. PubMed ID: 32579277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seabuckthorn Leaves Extract and Flavonoid Glycosides Extract from Seabuckthorn Leaves Ameliorates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obesity.
    Kwon EY; Lee J; Kim YJ; Do A; Choi JY; Cho SJ; Jung UJ; Lee MK; Park YB; Choi MS
    Nutrients; 2017 Jun; 9(6):. PubMed ID: 28574484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apigenin Ameliorates Dyslipidemia, Hepatic Steatosis and Insulin Resistance by Modulating Metabolic and Transcriptional Profiles in the Liver of High-Fat Diet-Induced Obese Mice.
    Jung UJ; Cho YY; Choi MS
    Nutrients; 2016 May; 8(5):. PubMed ID: 27213439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
    Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance.
    Gao S; McMillan RP; Zhu Q; Lopaschuk GD; Hulver MW; Butler AA
    Mol Metab; 2015 Apr; 4(4):310-24. PubMed ID: 25830094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mahoganoid mutation (Mgrn1md) improves insulin sensitivity in mice with mutations in the melanocortin signaling pathway independently of effects on adiposity.
    Phan LK; Chung WK; Leibel RL
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E611-20. PubMed ID: 16638826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice.
    Tsuchiya K; Sakai H; Suzuki N; Iwashima F; Yoshimoto T; Shichiri M; Hirata Y
    Endocrinology; 2007 Oct; 148(10):4548-56. PubMed ID: 17584959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic oral rapamycin decreases adiposity, hepatic triglycerides and insulin resistance in male mice fed a diet high in sucrose and saturated fat.
    den Hartigh LJ; Goodspeed L; Wang SA; Kenerson HL; Omer M; O'Brien KD; Ladiges W; Yeung R; Subramanian S
    Exp Physiol; 2018 Nov; 103(11):1469-1480. PubMed ID: 30117227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Very low-carbohydrate versus isocaloric high-carbohydrate diet in dietary obese rats.
    Axen KV; Axen K
    Obesity (Silver Spring); 2006 Aug; 14(8):1344-52. PubMed ID: 16988076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repetitive orogastric gavage affects the phenotype of diet-induced obese mice.
    de Meijer VE; Le HD; Meisel JA; Puder M
    Physiol Behav; 2010 Jun; 100(4):387-93. PubMed ID: 20385157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. At similar weight loss, dietary composition determines the degree of glycemic improvement in diet-induced obese C57BL/6 mice.
    Vangoitsenhoven R; van der Ende M; Corbeels K; Monteiro Carvalho Mori Cunha JP; Lannoo M; Bedossa P; van der Merwe S; Mertens A; Gesquiere I; Meulemans A; Matthys C; Mathieu C; Overbergh L; Van der Schueren B
    PLoS One; 2018; 13(7):e0200779. PubMed ID: 30036374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Template to improve glycemic control without reducing adiposity or dietary fat.
    Krishnapuram R; Dhurandhar EJ; Dubuisson O; Kirk-Ballard H; Bajpeyi S; Butte N; Sothern MS; Larsen-Meyer E; Chalew S; Bennett B; Gupta AK; Greenway FL; Johnson W; Brashear M; Reinhart G; Rankinen T; Bouchard C; Cefalu WT; Ye J; Javier R; Zuberi A; Dhurandhar NV
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E779-89. PubMed ID: 21266671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.